
Godrej Consumer Products Ltd Q2 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Long-term CAGR for the Soap category expected at 3% to 3.5%, with overall long-term category growth at 4% to 4.5%.
- Consumption in Soap category believed stable despite recent volume declines due to inventory corrections; volume upside expected soon.
- Single-digit volume growth anticipated in the second half of the fiscal year, driven by recovery in Household Insecticides, soap price normalization, and inventory correction in Indonesia.
- Continued focus on market development via advertising, sampling, and accessibility expected to support volume growth.
- Media investments have increased significantly (e.g., working media up 70%) to build categories like Air Care and Hair Color, driving future growth.
- Indonesia expected to move close to flat in Q3 with very high growth possible in Q4 onward.
- Household Insecticide volumes expected to return to normative levels after high COVID-19 related stocking in prior periods.
- Overall, cautious optimism on volume and sales growth despite current inflation and market challenges.
See what Godrej Consumer Products Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Godrej Consumer Products Ltd management said on order book — free account, 30 seconds.
Capex plans
YesTrack Godrej Consumer Products Ltd — get its next earnings analysis in your feed
How does Godrej Consumer Products Ltd rank vs peers in Personal Products?
Pro featureHow does Godrej Consumer Products Ltd rank in Personal Products?
Compare Godrej Consumer Products Ltd against every Personal Products company (Q2 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Godrej Consumer Products Ltd's management said in earlier quarters
Others in Personal Products this season
- Anondita Medicare Ltd (Q3 FY26)
Revenue from operations (Standalone) for H1 FY26: ₹4,765.06 lakh; H1 FY25: ₹2,497.06 lakh; YoY growth: 91% (Page 26) . Key investor presentation takeaways from
- Bajaj Consumer (Q2 FY27)
Q2 FY27 Net Sales Value: INR 332.7 Cr., up 27.3% YoY (Page 23) . Key investor presentation takeaways from Bajaj Consumer Care Ltd's Q2 FY27 investor presentatio
- Anondita Medicare Ltd (Q4 FY26)
Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…
- Cupid Ltd (Q4 FY24)
6,289 Lakhs, up 57.04% QoQ and 51.59% YoY from Rs. Key concall takeaways from Cupid Ltd's Q4 FY24 earnings call — and how it ranks against sector peers.